A new rapid home test for faecal calprotectin in ulcerative colitis

被引:52
作者
Elkjaer, M. [1 ]
Burisch, J. [1 ]
Hansen, V. Voxen [1 ]
Kristensen, B. Deibjerg [1 ]
Jensen, J-K. Slott [2 ]
Munkholm, P. [1 ]
机构
[1] Univ Copenhagen, Ctr Digest Dis, Herlev Hosp, Med Sect, Copenhagen, Denmark
[2] Slott Stat, Bagsvaerd, Denmark
关键词
INFLAMMATORY-BOWEL-DISEASE; INTESTINAL INFLAMMATION; CROHNS-DISEASE; RELAPSE; PROTEIN; LACTOFERRIN; VALIDATION; MARKER; L1;
D O I
10.1111/j.1365-2036.2009.04164.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
P>Background Enzyme-linked immunosorbent assay (ELISA) is a time-consuming method for the measurement of faecal calprotectin. Two new quantitative rapid tests have been developed. Aim To compare the new rapid tests with ELISA as 'Gold Standard'. Methods Quantitative analysis involved the application of a sample onto the 'Lateral Flow Device'. The colour intensity of a test line was read using a laptop computer linked to a scanner (rapid test scanning). A picture taken with a mobile phone (HT photo) of the same 'Lateral Flow Device' was sent to a server via Mobile Internet and the result appeared on the phone screen after 15 s. Results A total of 404 faecal samples were analysed. Mean differences of 1.7 mg/kg (range -23.4-20.1) ELISA vs. rapid test scanning, 6.8 mg/kg (-28-14.5) ELISA vs. HT photo and 2.9 mg/kg (-10.3-4.5) rapid test scanning vs. HT photo were found with good agreement calculated using kappa statistic (86%, 87% and 95% respectively). The Coefficients of Variation for HT photo was < 10%, with a sensitivity of 96.2% and a specificity of 90.1%. Conclusions The new rapid tests are accurate and useful in clinical settings. Feasibility of the home test as part of disease control and self-management is currently being investigated. Aliment Pharmacol Ther 31, 323-330.
引用
收藏
页码:323 / 330
页数:8
相关论文
共 22 条
[1]
Altman D. G., 1991, PRACTICAL STAT MED R, P410
[2]
Ulcerative colitis and irritable bowel syndrome: relationships with quality of life [J].
Ansari, Reza ;
Attari, Fatemeh ;
Razjouyan, Hadi ;
Etemadi, Arash ;
Amjadi, Hiva ;
Merat, Shahin ;
Malekzadeh, Reza .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2008, 20 (01) :46-50
[3]
STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[4]
Fecal calprotectin: Validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease [J].
Bunn, SK ;
Bisset, WM ;
Main, MJC ;
Gray, ES ;
Olson, S ;
Golden, BE .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2001, 33 (01) :14-22
[5]
Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease [J].
Costa, F ;
Mumolo, MG ;
Ceccarelli, L ;
Bellini, M ;
Romano, MR ;
Sterpi, C ;
Ricchiuti, A ;
Marchi, S ;
Bottai, M .
GUT, 2005, 54 (03) :364-368
[6]
Can calprotectin predict relapse risk in inflammatory bowel disease? [J].
D'Inca, Renata ;
Dal Pont, Elisabetta ;
Di Leo, Vincenza ;
Benazzato, Luca ;
Martinato, Matteo ;
Lamboglia, Francesca ;
Oliva, Lydia ;
Sturniolo, Giacomo Carlo .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (08) :2007-2014
[7]
Validation and clinical significance of a new calprotectin rapid test for the diagnosis of gastrointestinal diseases [J].
Damms, A. ;
Bischoff, S. C. .
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2008, 23 (10) :985-992
[8]
ELKJAER M, 2009, EUR J GASTROEN HEPAT, V21, P2326
[9]
IBD patients need in health quality of care ECCO consensus [J].
Elkjaer, Margarita ;
Moser, Gabrielle ;
Reinisch, Walter ;
Durovicova, Dana ;
Lukas, Milan ;
Vucelic, Boris ;
Wewer, Vibeke ;
Colombel, Jean Frederic ;
Shuhaibar, Mary ;
O'Morain, Colm ;
Politi, Patrizia ;
Odes, Selwyn ;
Bernklev, Tomm ;
Oresland, Tom ;
Nikulina, Inna ;
Belousova, Elena ;
Van der Eijk, Ingrid ;
Munkholm, Pia .
JOURNAL OF CROHNS & COLITIS, 2008, 2 (02) :181-188
[10]
FAGERHOL MK, 1980, SCAND J HAEMATOL, V24, P393